Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 551
Selected: 0
NCT IDTitle
NCT03258034A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer
NCT04140552Chinese Research Group of Gallbladder Cancer
NCT04516616Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer
NCT07330544A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine Therapy
NCT06379087Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC
NCT06022978Submucosal Saline Injection Followed by Endoscopic Ultrasound
NCT06863506Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC
NCT07691515Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma
NCT01968317Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma
NCT03647280The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer
NCT05420480Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant Therapy
NCT02630108TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma
NCT05955391TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)
NCT06200051Multi-cancer Joint Screening and Early Diagnosis and Treatment Project Based on the Combination of Chinese Traditional and Western Medicine in Lanxi City
NCT01612286Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma
NCT06836869Modified Tumor-free Techniques Operation to Cervical Cancer
NCT05780372Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma
NCT06046963Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites
NCT07177456Study on Safety and Efficacy of UCB-MNCs for Radiation-induced Lung Injury
NCT03015727Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma
NCT03121846Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy
NCT01926483Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection
NCT02813967S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer
NCT04084158A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
NCT01216527Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer
NCT02448966Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy
NCT01091376Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
NCT04356872The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma
NCT04790409Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations
NCT05739045Nivolumab Combined With SOX Used in the Perioperative Treatment
NCT03567629Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer
NCT05705583A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma
NCT06530719A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated Non-small Cell Lung Cancer Progression After Receiving Adjuvant Targeted Therapy Following Radical Surgery
NCT04291092Camrelizumab Combined With Local Treatment in NSCLC Patients With BM
NCT04850027MRI-guided Lateral Lymph Node Dissection in Rectal Cancer
NCT06383494GMA-Tulip, I-gel and the LMA-Supreme (LMA-S) Devices in Airway Management (GLAM-I)
NCT06190639A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC
NCT07849712An Exploratory Clinical Study Of Bempemab Combined With Anlotinib As First-Line Treatment For Elderly Patients With Locally Advanced Or Metastatic Non-Small-Cell Lung Cancer
NCT03761550pMDT in Thoracic Surgery--The Process Implementation Stage
NCT06766305QL1706 Combined With SOX Used in Theperioperative Treatment
NCT07065435RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study
NCT02481661Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC
NCT07349498Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
NCT06489288ERAS in Totally Laparoscopic Total Gastrectomy for Gastric Cancer
NCT02702323Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study
NCT06586801The Patient-Reported Outcomes in ALK Positive Advanced NSCLC in China
NCT04723875Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline
NCT01405079Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation
NCT07074353Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NCT07855757Retlirafusp Alfa Plus SOX and Intraperitoneal Nab-Paclitaxel for Advanced Gastric/GEJ Cancer With Malignant Ascites